| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |